$SILO just announced a collaboration with University of San Fransicso to study effects of anti inflammatory properties of psilocybin in patients with Parkinson’s and Bipolar disorder.
Inflammation has been an underlying mechanism in the pathophysiology of Parkinson’s Disease, chronic pain, and bipolar disorder.
Psilocybin and related compounds have demonstrated strong anti-inflammatory effects in animals
A better understanding of the anti-inflammatory effects of psilocybin will give researchers an opportunity to optimize psilocybin treatment
The study will take place at The Translational Psychedelic Research Program at UCSF where they aim to accelerate progress of impactful and accessible psychedelic treatments.
SILO was up 3.7% closing at $0.14 , tiny mc
full news release
https://pro.ceo.ca/@nasdaq/silo-pharma-announces-collaboration-with-university